Comparison

BET-IN-16 European Partner

Item no. TMO-T78989-50mg
Manufacturer TargetMol
CASRN 2089390-09-8
Amount 50 mg
Quantity options 100 mg 100 mg 50 mg 50 mg 5 mg 5 mg
Category
Type Peptides
Specific against other
Smiles C(C)(N1C=2C(C(=C1)C3=CC=C(C(O)=O)C=C3)=NC=C(C2)C=4C(C)=NOC4C)(C5=CC=CC=N5)C6=CC=CC=N6
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Shipping Condition Cool pack
Available
Manufacturer - Targets
Epigenetic Reader Domain
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
515, 56
Description
BET-IN-16 (Comp I), a bromodomain and extra-terminal (BET) inhibitor, demonstrates anticancer activity by impeding the growth of prostate cancer cells. It exhibits potent inhibitory effects with half-maximal inhibitory concentration (IC50) values of 0.043 μM for LNCaP cells and 0.034 μM for 22Rv1 cells [1].
Pathways
Chromatin/Epigenetic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close